Central nervous system neuroblastoma is a rare and aggressive childhood cancer that originates in nerve cells within the brain or spinal cord, presenting unique challenges for diagnosis and treatment in young patients.

What is Central Nervous System Neuroblastoma?

Central nervous system neuroblastoma is a rare type of cancer that develops from immature nerve cells, called neuroblasts, specifically within the brain and spinal cord. Unlike the more common form of neuroblastoma that typically appears in the adrenal glands or along the spine outside the central nervous system, this particular variant grows directly inside the brain or spinal cord structures. These tumors are classified as embryonal neuroendocrine tumors, meaning they arise from cells that were meant to develop during the early stages of a baby’s growth before birth.^[1][2]

The condition primarily affects children and represents an extremely uncommon diagnosis. Central nervous system neuroblastoma originates from neural crest cells, which are special cells that form early in development and eventually give rise to parts of the nervous system. When these cells fail to mature properly and instead begin growing uncontrollably within the brain or spinal cord, they form tumors that can cause serious health problems. The location of these tumors within such critical structures makes them particularly challenging to treat.^[2][16]

This type of neuroblastoma is distinct from the more frequently diagnosed neuroblastoma that occurs outside the central nervous system. While standard neuroblastoma accounts for about 800 new cases annually in the United States and is the most common cancer in babies, central nervous system neuroblastoma represents only a small fraction of these cases. The rarity of this condition means that much of what doctors understand about it comes from individual case reports rather than large research studies.^[3][14]

Epidemiology

Central nervous system neuroblastoma is exceptionally rare, with fewer than 500 cases documented in medical literature worldwide. Because it is so uncommon, gathering comprehensive statistical information about its incidence has been difficult. The disease primarily affects young children, with most cases diagnosed in patients under the age of five years. Some reports indicate that the peak incidence occurs around five years of age, though cases have been identified in older children and occasionally in young adults.^[14][15]

The demographic patterns for central nervous system neuroblastoma are not as well established as those for standard neuroblastoma due to the limited number of cases. However, the broader category of neuroblastoma shows that the condition is slightly more common in boys than in girls. For neuroblastoma in general, the median age at diagnosis is approximately 17 months, and about 37 percent of patients are diagnosed during infancy. Ninety percent of all neuroblastoma cases are identified before a child reaches five years of age.^[11][12]

Regarding racial and ethnic patterns, research on general neuroblastoma populations has found that non-Hispanic White children have a higher risk of developing the disease compared to other racial and ethnic groups. Studies examining cases between 2003 and 2019 showed that Hispanic patients had about half the risk, while non-Hispanic Black patients had roughly 73 percent of the risk seen in non-Hispanic White patients. However, it remains unclear whether these same patterns apply specifically to central nervous system neuroblastoma, given the small number of documented cases.^[11][12]

Causes

The exact cause of central nervous system neuroblastoma remains largely unknown. Like other forms of neuroblastoma, this cancer develops when immature nerve cells undergo genetic changes that cause them to grow and multiply uncontrollably. These changes occur at the level of the cell’s DNA, altering the instructions that normally tell cells when to grow, divide, and die. In the case of central nervous system neuroblastoma, these abnormal cells arise within the brain or spinal cord rather than in other parts of the nervous system.^[2][3]

Research has identified certain genetic mutations that play a role in neuroblastoma development. In particular, a gene called FoxR2 has been found to be activated in some central nervous system neuroblastomas. When this gene becomes abnormally active, it can drive tumor formation. Most cases of central nervous system neuroblastoma occur sporadically, meaning the genetic changes happen randomly rather than being passed down from parents. Scientists have not yet identified specific environmental exposures or behaviors during pregnancy that definitively increase the risk of this condition.^[5][15]

For the broader category of neuroblastoma, researchers know that mutations in genes such as ALK and PHOX2B are associated with inherited forms of the disease, though these account for only about 1 to 2 percent of all cases. In most children, neuroblastoma appears to result from genetic mutations that occur by chance during early development. The cells that should have matured into healthy nerve tissue instead remain in an immature state and begin forming tumors. Since central nervous system neuroblastoma is so rare, understanding its specific causes continues to be an area of active research.^[5][13]

Risk Factors

Because central nervous system neuroblastoma is so uncommon, clear risk factors specific to this variant have been difficult to establish. However, looking at neuroblastoma more broadly provides some insight. The most significant risk factor is age, with the vast majority of cases occurring in children under five years old. Infants and very young children are at the highest risk, and the condition is extremely rare in children older than ten years of age.^[3][13]

Family history plays a role in a small percentage of neuroblastoma cases. Children who have inherited genetic mutations in the ALK or PHOX2B genes from a parent face an increased risk of developing neuroblastoma. However, this accounts for only 1 to 2 percent of all cases, meaning that the overwhelming majority of affected children have no family history of the disease. Some children with certain genetic syndromes, such as Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, or Noonan syndrome, also have an elevated risk of developing neuroblastoma.^[5][19]

There is no evidence that parents can do anything during pregnancy to prevent central nervous system neuroblastoma, as the genetic changes typically occur spontaneously. Researchers have investigated whether exposures during conception or pregnancy might contribute to risk, but no definitive environmental factors have been identified. The condition does not appear to be linked to lifestyle choices, diet, or behaviors during pregnancy. This can be reassuring for families, though it also means there are currently no known prevention strategies.^[5]

Symptoms

The symptoms of central nervous system neuroblastoma vary greatly depending on where the tumor is located within the brain or spinal cord and how large it has grown. Because these tumors develop in such critical areas, they can interfere with normal brain and nervous system function in multiple ways. Many children initially present with symptoms related to increased pressure inside the skull, a condition called increased intracranial pressure. This can cause persistent and worsening headaches, vomiting that often occurs in the morning, and changes in vision or mental state.^[14][15]

Children with central nervous system neuroblastoma may also experience neurological symptoms that depend on the specific part of the brain or spinal cord affected. These can include difficulty with balance and coordination, changes in movement or strength in the arms or legs, seizures, or alterations in sensation. Some children develop problems with speech or swallowing if the tumor affects the areas of the brain responsible for these functions. Behavioral changes, confusion, or altered consciousness can occur when tumors cause swelling or increased pressure within the skull.^[14]

In some cases, children may show more general symptoms that parents or doctors might initially attribute to other common childhood illnesses. These include persistent fatigue, decreased appetite, and failure to meet developmental milestones appropriate for their age. Some children experience vision problems, including bulging eyes or changes in how the eyes move. When tumors are located in the spinal cord, children may develop weakness, numbness, or even paralysis in the legs, along with problems controlling bladder or bowel function.^[9][21]

Prevention

Unfortunately, there are currently no known methods to prevent central nervous system neuroblastoma. Because the genetic mutations that cause this cancer typically occur randomly during early development, often before birth, there are no lifestyle changes, dietary modifications, or preventive measures that parents can take to reduce the risk. The rarity of the condition and the lack of identified environmental triggers mean that prevention strategies have not been established.^[5]

For families with a known history of neuroblastoma or genetic syndromes associated with increased cancer risk, genetic counseling may be beneficial. Genetic counselors can help families understand their specific risks and discuss whether genetic testing might be appropriate. In cases where a child inherits a genetic mutation associated with neuroblastoma risk, doctors may recommend more frequent monitoring, though this does not prevent the disease from occurring if genetic changes are already present.^[19]

Since prevention is not currently possible, the emphasis remains on early detection and prompt treatment when symptoms appear. Parents and pediatricians should be aware of warning signs such as persistent headaches, vomiting, changes in behavior or development, and neurological symptoms. Regular well-child visits allow doctors to monitor growth and development and identify any concerning changes that might warrant further investigation. While this does not prevent the disease, it can lead to earlier diagnosis, which may improve treatment outcomes.^[21]

Pathophysiology

Central nervous system neuroblastoma develops through the abnormal growth and division of immature nerve cells within the brain or spinal cord. During normal development, neural crest cells migrate to various parts of the body where they mature into different types of nerve tissue. In neuroblastoma, these cells fail to complete their maturation process and instead remain in an immature state while continuing to multiply uncontrollably. When this happens within the central nervous system, tumors form in the brain or spinal cord rather than in the more typical locations outside these structures.^[7][16]

The biological mechanisms driving central nervous system neuroblastoma involve complex genetic and molecular changes. Research has identified activation of the FoxR2 gene in some of these tumors, which appears to play a critical role in their development. This gene, when abnormally activated, can drive the uncontrolled growth of neuroblasts within the central nervous system. Additionally, these tumors may express certain molecular markers such as Olig2, MAP2, SOX10, and synaptophysin, which help doctors identify them through laboratory testing. The genetic profile of individual tumors can vary, contributing to differences in how aggressive the cancer behaves.^[15]

As central nervous system neuroblastoma grows, the tumor mass can create several physical problems within the skull or spinal canal. Because these are confined spaces, any growing mass increases pressure on surrounding brain or spinal cord tissue. This can disrupt normal function by compressing healthy tissue, blocking the flow of cerebrospinal fluid (the liquid that cushions the brain and spinal cord), or interfering with blood supply. The tumor may also invade nearby structures, further damaging healthy tissue. In some cases, these tumors can spread to other parts of the central nervous system through the cerebrospinal fluid, though this appears less common than in other types of childhood brain tumors.^[14]

The cellular characteristics of central nervous system neuroblastoma show poorly differentiated cells, meaning they look very immature and quite different from normal, mature nerve cells when examined under a microscope. These tumors may contain areas of dead tissue, calcifications, or cystic spaces filled with fluid. The aggressive nature of many central nervous system neuroblastomas reflects their high-grade biology, meaning the cells divide rapidly and the tumor grows quickly. Understanding these pathophysiological features helps doctors determine the best treatment approaches and predict how the cancer might behave over time.^[14][15]